Who is sponsoring NCT04335734?

NCT04335734 is sponsored by Grubnik Volodymyr.

What drugs are being tested in NCT04335734?

Interventions in NCT04335734: Nissen Fundoplication with wrap fixation, Nissen Fundoplication without wrap fixation.

What condition does NCT04335734 study?

NCT04335734 studies Gastro Oesophageal Reflux Disease.

Is NCT04335734 still recruiting?

NCT04335734 is currently completed. Last updated 6 April 2020.

Last reviewed 2020-04-06 · How we verify

NCT04335734

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Wrap Fixation Technique on the Results of Fundoplication

Completed NA Last updated 6 April 2020

What this trial tests

NA trial testing Nissen Fundoplication with wrap fixation in Gastro Oesophageal Reflux Disease in 138 participants. Completed in 28 May 2019.

Timeline

1 November 2012

Primary endpoint
1 October 2014

28 May 2019

Quick facts

Lead sponsor	Grubnik Volodymyr
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	138
Start date	1 November 2012
Primary completion	1 October 2014
Estimated completion	28 May 2019

Drugs / interventions tested

Nissen Fundoplication with wrap fixation
Nissen Fundoplication without wrap fixation

Conditions studied

Gastro Oesophageal Reflux Disease — all drugs for Gastro Oesophageal Reflux Disease →

Sponsor

Grubnik Volodymyr

Who can join

Adults 20 to 80, any sex, with Gastro Oesophageal Reflux Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients who underwent anti-reflux surgery were divided into two groups. In the I group Nissen fundoplication was supplemented with suturing wrap to the crura or the body of stomach using two non-absorbable stitches on each side. Control group included patients who underwent classic Nissen fundoplication without wrap fixation. All patients were assessed before and after surgery using validated symptoms and quality of life (GERD-HRQL) questionnaires, 24-h impedance-pH monitoring and barium-swallow.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Grubnik Volodymyr trials

Trials by the same sponsor.

NCT04152798 — Approach to Hiatal Hernia Repair Based on Collagen Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04335734 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Grubnik Volodymyr
Last refreshed: 6 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04335734.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing